BRISTOL MYERS SQUIBB CO (BMY) Earnings History

8 quarters held2/4 transcripts analyzed2/40 figures attestedNext: Oct 29, 2026, 8:00 AM
Connect your agent
PeriodRevenueYoYNet incomeEPS (dil.)Filed
Q2 2026$13.0B+5.7%$3.3B$1.62Jul 30, 2026
LATESTEarnings filing (8-K)10-QFiled Jul 30, 2026, 7:05 AM ET
Earnings call · Jul 30, 2026deckdeckwebcast
Q2 FY26YoY
Revenue$13.0B1+5.7%
Net income$3.3B+153.2%
Op income––
EPS (dil.)$1.62+153.1%
EPS (basic)$1.62+153.1%
Gross margin71.3%-1.2pp
Net margin25.6%+14.9pp
  1. [1] “Total Revenues $12,973 $12,269 6 % 5 %” view source

Guidance & outlook

Management guidance

Q2 2026

fy_current

revenue
$49.0B—$50.0B
eps_diluted
$6.75—$7.00
Q1 2026$11.5B+2.6%$2.7B$1.31Apr 30, 2026
10-QFiled Apr 30, 2026, 7:01 AM ET
Earnings call · Apr 30, 2026transcriptView originalprepared remarksQ&Adeckdeckwebcast
Q1 FY26YoY
Revenue$11.5B1+2.6%
Net income$2.7B+9.0%
Op income––
EPS (dil.)$1.31+9.2%
EPS (basic)––
Net margin23.3%+1.4pp
  1. [1] “Total Revenues $11,489” view source
Q4 2025$12.5B+1.3%$1.1B$0.53Feb 5, 2026
Earnings filing (8-K)10-KFiled Feb 5, 2026, 7:07 AM ET
Earnings call · Feb 5, 2026transcriptprepared remarksQ&Adeckdeckwebcast
Q4 FY25YoYFY25
Revenue$12.5B+1.3%$48.2B
Net income$1.1B–$7.1B
Op income–––
EPS (dil.)$0.53+1225.0%–
EPS (basic)$0.53+1225.0%–
Gross margin67.2%+6.2pp
Net margin8.7%+8.1pp
Q3 2025$12.2B+3.0%$2.2B$1.08Oct 30, 2025
Earnings filing (8-K)10-QFiled Oct 30, 2025, 7:09 AM ET
Earnings calldeckdeckwebcast
Q3 FY25YoY9M FY25
Revenue$12.2B+3.0%–
Net income$2.2B+81.8%$6.0B
Op income–––
EPS (dil.)$1.08+80.0%$2.93
EPS (basic)$1.08+80.0%$2.93
Gross margin71.9%-3.2pp
Net margin18.0%+8.0pp
Q2 2025$12.3B+1.0%$1.3B$0.64Jul 31, 2025
Earnings filing (8-K)10-QFiled Jul 31, 2025, 7:06 AM ET
Earnings calldeckdeckwebcast
Q2 FY25YoY6M FY25
Revenue$12.3B+1.0%–
Net income$1.3B-22.0%$3.8B
Op income–––
EPS (dil.)$0.64-22.9%$1.85
EPS (basic)$0.64-22.9%$1.85
Gross margin72.5%-0.7pp
Net margin10.7%-3.1pp
Q1 2025––––Apr 24, 2025
10-QFiled Apr 24, 2025, 7:11 AM ET
Earnings call · Apr 24, 2025deckdeckwebcast
Q1 FY25YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––
Q4 2024––––Feb 6, 2025
10-KFiled Feb 6, 2025, 7:46 AM ET
Earnings calldeckdeckwebcast
Q4 FY24YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––
Q3 2024––––Oct 31, 2024
10-QFiled Oct 31, 2024, 7:52 AM ET
Earnings calldeckdeckwebcast
Q3 FY24YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––

IR event calendar

Upcoming
  • Bristol Myers Squibb Q3 2026 Results Conference CallOct 29, 2026, 8:00 AM
Past
  • Bristol Myers Squibb Q2 2026 Results Conference CallJul 30, 2026, 8:15 AM
    webcastdata_xlsxdocumentpresentationpresentationpress_releasewebcast
  • Goldman Sachs 47th Annual Global Healthcare ConferenceJun 9, 2026, 2:00 PM
    webcastwebcast
  • Bank of America Securities Health Care ConferenceMay 14, 2026, 11:40 AM
    webcastwebcast
  • Bristol Myers Squibb Q1 2026 Results Conference CallApr 30, 2026, 8:00 AM
    webcastdata_xlsxdocumentpresentationpresentationpress_releasewebcast
  • 46th Annual TD Cowen Health Care ConferenceMar 2, 2026, 9:50 AM
    webcastwebcast
  • Bristol Myers Squibb Q4 2025 Results Conference CallFeb 5, 2026, 8:00 AM
    webcastdata_xlsxdocumentpresentationpresentationpress_releasewebcast

+75 more

IR event calendar last checked 2026-08-15 19:00:04+00; events announced since are not shown.

Filing coverage

57 filings indexed · 72,442 XBRL facts
FilingDatePeriodSectionsTables
10-Q2026-07-30–39101
8-K2026-07-30Q2 202680
8-K2026-05-08–10
10-Q2026-04-30–3771
8-K2026-04-30Q1 202690
10-K2026-02-11FY 66188
8-K2026-02-05Q4 202580
8-K2025-11-18–20
8-K2025-11-10–20
8-K2025-11-03–20

Showing the latest 10 of 57 — the full set is in the API.

Related Research

Analysis

The $15 Billion Earnings Illusion Behind AbbVie's 96x P/E